EarningsQ2 2024 Earnings Report

Moderna (MRNA) Q2 2024 Earnings Report

1 Followers

MX:MRNA Q2 2024 EPS Results

Actual EPS-$60.53

Consensus EPS-$60.86

Beat/MissBeat by +$0.33

One Year Ago EPS-$65.81

Actual Revenue$4.38B

Expected Revenue$2.33B

Beat/MissBeat by +$2.05B

YoY Revenue Growth-29.94%

QuarterQ2 2024

Date08/01/2024

TimeBefore Open

Conference CallThursday, August 1, 2024

MX:MRNA Upcoming Earnings

Moderna's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:MRNA Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-19.96 / -	-9.271	―
Jul 31, 2026	2026 (Q2)	-36.94 / -35.81	-38.72	7.51% (+2.91)
May 01, 2026	2026 (Q1)	-80.82 / -61.81	-45.809	-34.92% (-16.00)
Feb 13, 2026	2025 (Q4)	-46.25 / -38.36	-52.899	27.49% (+14.54)
Nov 06, 2025	2025 (Q3)	-34.08 / -9.27	0.545	-1800.00% (-9.82)
Aug 01, 2025	2025 (Q2)	-54.33 / -38.72	-60.533	36.04% (+21.81)
May 01, 2025	2025 (Q1)	-56.64 / -45.81	-55.807	17.92% (+10.00)
Feb 14, 2025	2024 (Q4)	-48.72 / -52.90	9.998	-629.09% (-62.90)
Nov 07, 2024	2024 (Q3)	-32.81 / 0.55	-173.238	100.31% (+173.78)
Aug 01, 2024	2024 (Q2)	-60.86 / -60.53	-65.805	8.01% (+5.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed